ISSUE DATE: May 17, 2021
UPDATED: May 7, 2021 23:36 IST
Staff at the Ghazipur crematorium in Delhi cart in fresh logs as
funeral pyres burn all around them (Rajk Raj/ Getty Images)
The second wave of Covid-19 is still cresting but by now we have all been touched by its terrors, and all too many of us by its sorrows and the dismal realisation that we are in the midst of a recurring nightmare, a tragedy foretold. Here, we expose the sorry tale of neglect, apathy and failure of our political leadership. The institutional collapse and bureaucratic cowardice that facilitated super-spreader religious festivals and the political carnival of an eight-phase election campaign even as the second wave of a pandemic was breaking. The narcissism that enabled our leadership to ignore the warnings of expert groups. Their inability to form bipartisan alliances between the Centre and the states in the middle of a national calamity. Now that some of the loudest voices in the land have gone quiet, t
Inside Remdesivir puzzle: 6 producers, little supply!
Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing
PB Jayakumar | May 3, 2021 | Updated 19:22 IST
Demand for Remdesivir fell to almost nil by January after the first wave of the pandemic in the country
Reduction in production due to less demand after the first wave of coronavirus and lack of vigil on the part of the Government to ensure stockpiling led to current Remdesivir crisis, say sources.
Gilead Life Sciences, the innovator of the re-purposed drug, had licensed six manufacturers in India to produce the drug. Most of them were dependent on contract manufacturers and their subsidiaries to make the product. Demand fell to almost nil by January after the first wave of the pandemic in the country. Since there was no demand, most manufacturers stopped giving fresh orders for manufacturing. Neith
Covid-19: Why is there a shortage of Remdesivir?- Business News businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Govt to import 4.5 lakh vials of antiviral drug Remdesivir amid spike in COVID-19 cases
NEW DELHI, Apr 30: The Government has placed orders for import of 4.5 lakh vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, Chemicals and Fertilisers Ministry said in a statement.
The Government has started importing the vital drug from other countries to ease its shortage in the country, it said.
The first consignment of 75,000 vials will reach India on Friday, it added.
Demand for Remdesivir has gone up manifold in the country with a surge in COVID-19 cases.